Oncolytics Biotech Inc. Financial Ratios — ONCY Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-80.32	-167.04	-123.73	-97.9	-66.63	-87.54	-170.82	-224.65	- -	- -	-86.46	-76.5	-103.81	-189.36	- -
Return on Assets (%)	-71.38	-127.23	-90.77	-77.64	-57.25	-73.35	-97.73	-98.7	-195.33	-84.08	-65.58	-57.64	-73.7	-106.8	-273.86
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-80.32	-167.04	-123.73	-97.9	-66.63	-87.54	-170.82	-224.65	- -	- -	-86.46	-76.5	-103.81	-189.36	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.03	-0.02	-0.03	-0.01	-0.01	-0.03	-0.02
Net Debt/EBITDA	1.15	0.53	1.06	0.76	1.75	0.8	0.76	0.8	0.71	1.25	1.6	0.44	1.05	0.44	0.18
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.02	-0.02	-0.02	-0.01	-0.01	-0.03	-0.02
Net Debt/EBIT	1.15	0.53	1.06	0.75	1.73	0.79	0.76	0.79	0.69	1.23	1.57	0.43	1.03	0.43	0.18
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	81.95	66.97	78.71	80.38	90.11	72.43	45.64	41.68	-0.55	72.07	78.68	70.99	71	24.57	-50.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.62	1	0.59	1.05	17.01	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	41.78	0.61	0.98	0.58	1.04	13.82	-11.43
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.85	0.45	0.79	0.42	0.75	4.18	4.88
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	-469.23	1.62	1.81	1.41	1.53	23.07	-14.82
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	127.08	1.6	1.78	1.39	1.51	18.75	-17.4
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.58	1.17	1.43	1	1.09	5.67	7.43
Net Debt to Equity	-111.51	-130.68	-113.54	-102.41	-97.33	-112.58	-142.88	-221.13	13,112.89	-126.12	-114.3	-44.02	-126.66	-335.93	136.93
Net Debt/Capital (%)	968.66	425.93	838.73	4,242.05	-3,649.72	894.97	333.2	182.56	102.9	514.79	915.31	-76.7	504.07	157.82	61.65
EBITDA	-28	-37	-22	-16	-10	-11	-12	-13	-15	-20	-20	-20	-25	-25	-29
EBITDA-CapEx	-28	-37	-23	-16	-10	-11	-12	-13	-15	-20	-20	-20	-25	-26	-29
Operating Income (Loss)	-28	-37	-22	-16	-10	-11	-12	-13	-16	-20	-21	-20	-25	-26	-29

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	5.36	2.92	4.53	4.8	9.62	3.47	2.26	4.87	1.1	11.52	15.34	8.15	8.24	2.27	0.85
Current Ratio	5.48	2.97	4.61	4.94	9.94	3.55	3.41	5.13	1.47	12.45	16.69	9.05	9.01	2.55	1.12
Quick Ratio	5.37	2.93	4.55	4.85	9.75	3.48	3.18	4.89	1.26	11.56	15.66	8.28	8.24	2.28	0.95
CFO/Avg Current Liab	-4.98	-5.03	-3.54	-3.97	-4.46	-3.73	-3.3	-2.81	-2.56	-2.89	-8.31	-6.86	-7.03	-4.92	-3.66
Common Equity/Total Assets	81.95	66.97	78.71	80.38	90.11	72.43	45.64	41.68	-0.55	72.07	78.68	70.99	71	24.57	-50.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.62	1	0.59	1.05	17.01	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	41.78	0.61	0.98	0.58	1.04	13.82	-11.43
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.85	0.45	0.79	0.42	0.75	4.18	4.88
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	-469.23	1.62	1.81	1.41	1.53	23.07	-14.82
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	127.08	1.6	1.78	1.39	1.51	18.75	-17.4
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.58	1.17	1.43	1	1.09	5.67	7.43
CFO/Total Liabilities	-346.56	-469.81	-406.76	-583.19	-554.89	-306.68	-150.93	-137.49	-100.71	-230.05	-229.35	-215.61	-252.71	-196.41	-176.72
CFO/CapEx	-87.44	-270.98	-95.91	-128.82	-138.87	-530.35	-140.8	-110.92	-1,825.41	-760.97	-78.44	-424.64	-3,556	-114.27	-3,352
Altman's Z-Score	17.85	6.74	0.63	-12.8	-4.28	-23.97	-18.53	-29.26	-21.52	-7.56	-6.8	-9.53	-10.8	-43.07	-86.71

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	1.33	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	274.28	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	278	301	131	50	32	26	81	31	153	110	77	100	100	73	94
- Cash & Cash Equivalents	32	19	24	12	17	9	9	10	11	24	32	9	26	11	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1	1
Enterprise Value	244	279	106	36	13	15	71	21	143	86	45	77	74	63	90
Total Capital	29	15	21	12	18	8	7	5	- -	20	29	20	21	4	-3
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	127.08	1.6	1.78	1.39	1.51	18.75	-17.4
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	- -	- -	0.01	0.01
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	277	298	130	47	30	25	76	29	105	96	74	95	91	70	84
Diluted Enterprise Value	244	279	106	34	13	16	66	19	95	72	43	86	65	60	79
EV per Share	32.5	34.59	11.87	3.62	1.06	1.18	4.79	1.23	4.44	1.86	0.81	1.25	1	0.78	0.83
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-28	-37	-22	-16	-10	-11	-12	-13	-15	-20	-20	-20	-25	-25	-29
TTM Operating Income	-28	-37	-22	-16	-10	-11	-12	-13	-16	-20	-21	-20	-25	-26	-29
TTM Cash Flow to Firm	-22	-34	-23	-17	-11	-9	-12	-9	-15	-17	-18	-17	-21	-20	-20
TTM Free Cash Flow to Firm	-22	-34	-23	-17	-11	-9	-12	-9	-15	-17	-17	-17	-21	-20	-20

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-12.67	-8.7	-5.7	-2.77	-2.83	-2.72	-6.42	-3.34	-6.92	-5.55	-4.28	-5.51	-4.26	-3.55	-4.17
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	244	279	106	36	13	15	71	21	143	86	45	77	74	63	90
Low Price	29.92	15.2	13.78	3.8	2.28	1.33	1.81	1.64	0.35	0.94	1.37	0.8	1.09	0.71	0.33
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-12.63	-7.09	-10.71	-6.81	-6.38	-3.31	-4.75	-6.07	-1.3	-4.92	-6.57	-4.47	-5.85	-3.54	-2.9
Price/Earnings High	-17.25	-12.2	-18.63	-11.34	-15.94	-6.28	-9.06	-10.95	-5.26	-11.02	-12.53	-7.23	-10.96	-5.13	-5.03
Price/Earnings Low	-7.85	-3.33	-5.48	-2.19	-2.73	-1.49	-2.03	-2.1	-0.31	-2.15	-3.55	-2.54	-3.52	-2.38	-1.09
Price/Book Value	9.61	20.23	6.3	4.17	1.8	3.21	12.28	6.92	-1,855.57	5.66	2.7	5.12	4.84	22.17	-24.85
Price/Book Value Average	12.48	17.59	11.52	9.76	3.72	4.75	9.59	18.14	-580.62	5.11	4.92	4.42	6.49	25.63	-24.74
Price/Book Value High	17.05	30.24	20.04	16.26	9.3	9	18.29	32.71	-2,346.75	11.46	9.39	7.16	12.14	37.12	-42.94
Price/Book Value Low	7.76	8.26	5.9	3.14	1.59	2.13	4.1	6.27	-136.44	2.24	2.66	2.51	3.9	17.23	-9.26
Price/Tangible Book Value	9.61	20.23	6.3	4.17	1.8	3.21	12.28	6.92	-1,855.57	5.66	2.7	5.12	4.84	22.17	-24.85
Price/Tangible Book Value Average	12.48	17.59	11.52	9.76	3.72	4.75	9.59	18.14	-580.62	5.11	4.92	4.42	6.49	25.63	-24.74
Price/Tangible Book Value High	17.05	30.24	20.04	16.26	9.3	9	18.29	32.71	-2,346.75	11.46	9.39	7.16	12.14	37.12	-42.94
Price/Tangible Book Value Low	7.76	8.26	5.9	3.14	1.59	2.13	4.1	6.27	-136.44	2.24	2.66	2.51	3.9	17.23	-9.26
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-12.53	-8.66	-5.64	-2.75	-2.81	-2.72	-6.38	-3.31	-6.91	-5.55	-4.23	-5.5	-4.26	-3.52	-4.17
Price/Cash Flow Average	-16.27	-7.53	-10.31	-6.44	-5.83	-4.02	-4.98	-8.68	-2.16	-5.01	-7.7	-4.75	-5.71	-4.06	-4.15
Price/Cash Flow High	-22.23	-12.95	-17.94	-10.73	-14.55	-7.63	-9.5	-15.65	-8.75	-11.23	-14.69	-7.69	-10.69	-5.89	-7.2
Price/Cash Flow Low	-10.12	-3.54	-5.28	-2.07	-2.49	-1.81	-2.13	-3	-0.51	-2.19	-4.17	-2.7	-3.44	-2.73	-1.55
Price/Free Cash Flow Average	-16.46	-7.56	-10.42	-6.49	-5.87	-4.03	-5.02	-8.76	-2.16	-5.02	-7.8	-4.76	-5.71	-4.1	-4.15
Price/Free Cash Flow High	-22.48	-13	-18.13	-10.82	-14.66	-7.64	-9.57	-15.79	-8.75	-11.25	-14.88	-7.71	-10.69	-5.94	-7.2
Price/Free Cash Flow Low	-10.23	-3.55	-5.33	-2.09	-2.51	-1.81	-2.15	-3.03	-0.51	-2.19	-4.22	-2.7	-3.44	-2.76	-1.55
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-11.72	-6.58	-9.71	-6.47	-4.94	-2.56	-4.36	-5.75	-2.46	-3.83	-5.32	-3.99	-4.32	-2.92	-3.12
EV/EBITDA High	-16.43	-11.7	-17.67	-11.29	-14.96	-5.57	-9	-11	-12.04	-10.11	-11.57	-6.73	-8.99	-4.4	-5.53
EV/EBITDA Low	-6.85	-2.81	-4.45	-1.57	-1.12	-0.71	-1.43	-1.47	-0.05	-0.98	-2.15	-2.08	-2.19	-1.83	-1.07
EV/EBIT Average	-11.69	-6.56	-9.65	-6.41	-4.88	-2.53	-4.33	-5.71	-2.4	-3.76	-5.23	-3.93	-4.27	-2.91	-3.11
EV/EBIT High	-16.38	-11.66	-17.57	-11.19	-14.77	-5.51	-8.95	-10.94	-11.76	-9.94	-11.37	-6.63	-8.88	-4.39	-5.52
EV/EBIT Low	-6.83	-2.8	-4.43	-1.55	-1.1	-0.71	-1.42	-1.46	-0.05	-0.96	-2.12	-2.05	-2.16	-1.82	-1.06
Last Price	37.05	37.24	14.73	5.04	2.57	2	5.42	1.81	4.76	2.38	1.39	1.63	1.35	0.91	0.87
High Price	65.74	55.67	46.83	19.67	13.3	5.61	8.07	8.55	6.02	4.82	4.83	2.28	3.39	1.53	1.51
Enterprise Value Average	329	242	217	104	49	29	54	72	38	75	108	78	109	74	89
Enterprise Value High	461	430	394	181	148	63	111	139	183	198	234	132	226	112	158
Enterprise Value Low	192	103	99	25	11	8	18	18	1	19	44	41	55	47	31

Shares Outstanding	8	8	9	10	12	13	15	17	32	46	55	61	74	80	108
Diluted Weighted Avg Shares	7	8	9	9	12	13	14	16	22	40	54	58	68	76	96
Basic Weighted Avg Shares	7	8	9	9	12	13	14	16	22	40	54	58	68	76	96
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-3.76	-4.59	-2.54	-1.74	-0.84	-0.89	-0.89	-0.79	-0.69	-0.49	-0.38	-0.34	-0.37	-0.33	-0.3
Operating Income per Share	-3.77	-4.6	-2.55	-1.75	-0.85	-0.9	-0.89	-0.79	-0.7	-0.49	-0.38	-0.34	-0.38	-0.33	-0.3
Basic EPS, GAAP	-3.81	-4.56	-2.51	-1.73	-0.83	-0.89	-0.89	-0.78	-1.15	-0.44	-0.39	-0.32	-0.31	-0.3	-0.3
Basic EPS from Cont Ops	-3.81	-4.56	-2.51	-1.73	-0.83	-0.89	-0.89	-0.78	-1.15	-0.44	-0.39	-0.32	-0.31	-0.3	-0.3
Diluted EPS, GAAP	-3.81	-4.56	-2.51	-1.73	-0.83	-0.89	-0.89	-0.78	-1.15	-0.44	-0.39	-0.32	-0.31	-0.3	-0.3
Diluted EPS from Cont Ops	-3.81	-4.56	-2.51	-1.73	-0.83	-0.89	-0.89	-0.78	-1.15	-0.44	-0.39	-0.32	-0.31	-0.3	-0.3
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.96	-4.3	-2.61	-1.83	-0.91	-0.74	-0.85	-0.55	-0.69	-0.43	-0.33	-0.3	-0.32	-0.26	-0.21
Free Cash Flow per Basic Share	-2.99	-4.31	-2.64	-1.85	-0.92	-0.74	-0.86	-0.55	-0.69	-0.43	-0.33	-0.3	-0.32	-0.26	-0.21
Cash & Equivalents per Share	4.55	2.65	2.86	1.42	1.51	0.82	0.63	0.58	0.34	0.53	0.59	0.39	0.35	0.14	0.05
Book Value per Share	3.86	1.84	2.34	1.21	1.43	0.62	0.44	0.26	- -	0.42	0.51	0.32	0.28	0.04	-0.04
Tangible Book Value per Share	3.86	1.84	2.34	1.21	1.43	0.62	0.44	0.26	- -	0.42	0.51	0.32	0.28	0.04	-0.04

Oncolytics Biotech Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)